logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5632.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5632.produseast1
Showing 1 - 8 of 8 Items
Showing 1 - 8 of 8 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Screening patients with tuberculosis for diabetes mellitus in Ampara, Sri Lanka

Rajapakshe W, Isaakidis P, Sagili KD, Kumar AMV, Samaraweera S,  et al.
2015-06-21 • Public Health Action
2015-06-21 • Public Health Action
Given the well-known linkage between diabetes mellitus (DM) and tuberculosis (TB), the World Health Organization recommends bidirectional screening. Here we report the first screening ef...
Journal Article
|
Research

Combination Treatment for Visceral Leishmaniasis Patients Co-infected with Human Immunodeficiency Virus in India

Mahajan R, Das P, Isaakidis P, Sunyoto T, Sagili KD,  et al.
2015-06-30 • Clinical Infectious Diseases
2015-06-30 • Clinical Infectious Diseases
There are considerable numbers of patients co-infected with Human Immunodeficiency Virus (HIV) and Visceral Leishmaniasis (VL) in the VL-endemic areas of Bihar, India. These patients are...
Journal Article
|
Research

Operational research within a Global Fund supported tuberculosis project in India: why, how and its contribution towards change in policy and practice

Sagili KD, Satyanarayana S, Chadha SS, Wilson NC, Kumar AMV,  et al.
2018-02-01 • Global Health Action
2018-02-01 • Global Health Action
BACKGROUND:
The Global Fund encourages operational research (OR) in all its grants; however very few reports describe this aspect. In India, Project Axshya was supported by a Global...
Journal Article
|
Research

Loss-to-follow-up on multidrug resistant tuberculosis treatment in Gujarat, India: the WHEN and WHO of itt

Shringarpure KS, Isaakidis P, Sagili KD, Baxi RK
2015-07-13 • PLOS One
2015-07-13 • PLOS One
BACKGROUND
Multidrug-resistant Tuberculosis (MDR-TB) is a rising global threat to public health and concerted efforts for its treatment are diluted if the outcomes are not successful...
Journal Article
|
Research

Do Incentivised Community Workers in Informal Settlements Influence Maternal and Infant Health in Urban India?

Verma H, Sagili KD, Zachariah R, Agarwal A, Dongre A,  et al.
2017-03-21 • Public Health Action
2017-03-21 • Public Health Action
Setting: The introduction of accredited social health activists (ASHAs, community workers) in the community is encouraged by the Government of India as being of universal benefit for mat...
Journal Article
|
Research

The multi-drug resistant tuberculosis diagnosis and treatment cascade in Bangladesh

Hossain ST, Isaakidis P, Sagili KD, Islam S, Islam MS,  et al.
2015-06-25 • PLOS One
2015-06-25 • PLOS One
OBJECTIVES
To determine, in areas supported by BRAC, Bangladesh i) the pre-diagnosis and pre-treatment attrition among presumptive and confirmed Multi-Drug Resistant Tuberculosis (MD...
Journal Article
|
Research

"They Know, They Agree, but They Don't Do"- The Paradox of Tuberculosis Case Notification by Private Practitioners in Alappuzha District, Kerala, India

Philip S, Isaakidis P, Sagili KD, Meharunnisa A, Mrithyunjayan S,  et al.
2015-04-24 • PLOS One
2015-04-24 • PLOS One
Despite being a recognized standard of tuberculosis (TB) care internationally, mandatory TB case notification brings forth challenges from the private sector. Only three TB cases were no...
Journal Article
|
Research

"When treatment is more challenging than the disease": A qualitative study of MDR-TB patient retention

Shringarpure KS, Isaakidis P, Sagili KD, Baxi RK, Das M,  et al.
2016-03-09 • PLOS One
2016-03-09 • PLOS One
BACKGROUND
One-fifth of the patients on multidrug-resistant tuberculosis treatment at the Drug-Resistant-TB (DR-TB) Site in Gujarat are lost-to-follow-up(LFU).

OBJECTIVE